Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial - Test2 - elhamkhani - TriplyDB

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

http://www.wikidata.org/entity/Q29547224

about

Improving the extent of malignant glioma resection by dual intraoperative visualization approach Combined RNAi-mediated suppression of Rictor and EGFR resulted in complete tumor regression in an orthotopic glioblastoma tumor model Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer Mutational profiling of kinases in glioblastoma.A novel volume-age-KPS (VAK) glioblastoma classification identifies a prognostic cognate microRNA-gene signature Antiangiogenic therapy for high-grade glioma Temozolomide for high grade glioma Anti-angiogenic therapy for high grade glioma Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP Mechanistic evaluation of the novel HSP90 inhibitor NVP-AUY922 in adult and pediatric glioblastoma miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression Hes3 regulates cell number in cultures from glioblastoma multiforme with stem cell characteristics.MiRNA expression patterns predict survival in glioblastoma Recent advances in the molecular understanding of glioblastoma External beam radiation dose escalation for high grade glioma Gliadel wafer implantation combined with standard radiotherapy and concurrent followed by adjuvant temozolomide for treatment of newly diagnosed high-grade glioma: a systematic literature review CD8 T Cell-Independent Antitumor Response and Its Potential for Treatment of Malignant Gliomas High-grade glioma management and response assessment-recent advances and current challenges CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseases Malignant gliomas: old and new systemic treatment approaches The evolving roles and controversies of radiotherapy in the treatment of glioblastoma MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics Cancer Stem Cell Hierarchy in Glioblastoma Multiforme Radioresistance of Brain Tumors Therapeutic interactions of autophagy with radiation and temozolomide in glioblastoma: evidence and issues to resolve Glioma Stem Cells and Their Microenvironments: Providers of Challenging Therapeutic Targets Glioma Stem Cells: Signaling, Microenvironment, and Therapy Immune Evasion Strategies of Glioblastoma PI3K/Akt/mTOR signaling pathway and targeted therapy for glioblastoma Concurrent therapy to enhance radiotherapeutic outcomes in glioblastoma Genetics and Epigenetics of Glioblastoma: Applications and Overall Incidence of IDH1 Mutation Stereotactic Radiosurgery for Glioblastoma Epidermal growth factor, latrophilin, and seven transmembrane domain-containing protein 1 marker, a novel angiogenesis marker Advances in the treatment of newly diagnosed glioblastoma Therapeutic approach beyond conventional temozolomide for newly diagnosed glioblastoma: Review of the present evidence and future direction Bevacizumab for glioblastoma miRNA interventions serve as 'magic bullets' in the reversal of glioblastoma hallmarks The TWEAK receptor Fn14 is a potential cell surface portal for targeted delivery of glioblastoma therapeutics The progress of immunotherapy for glioblastoma Current trends in the surgical management and treatment of adult glioblastoma

P2860

Q21090866-30AFB442-DB68-4FC8-BE7D-DA0CDE70B6A2 Q21133610-B74D8E53-5310-4695-AA36-CDE070E269DF Q21203116-CA2A4D4C-AC9C-4A26-8A74-11BF65AA87B1 Q21261249-E8BD7DF6-CE99-48B3-84B4-846B5F5C89CB Q21560781-7732D949-D5B6-463C-8C28-D981D9EE1554 Q24193485-332AA265-F4E2-4F2C-B2B2-F7B9E246972F Q24197645-06D48F8E-B1BF-4248-81BB-1A3C20C3365F Q24240185-F1EB8351-3D4A-403A-BC28-854760FFCE7E Q24302531-0B4127F8-DB33-4C70-A416-4D30EB42DE2A Q24607424-A1A1B99E-8DBE-4EAA-881C-46195EF555A6 Q24610377-604A7C6B-2C35-40FA-B584-2943B220218D Q24625571-7C8179A3-9B74-4ACF-BEEE-A30B313E1236 Q24629525-653828BC-C784-4F21-8FC1-66EC41C47321 Q24632928-FEBA1370-227F-40D3-9632-544CF44DEF1D Q26470382-5B409F78-63E6-46D6-9FB9-4C7FC44254D2 Q26739012-E540FA9A-798A-4FC4-A3B1-E5C65620EB36 Q26740520-C91CA4C5-6950-417A-B5C9-00B4A5BCEE69 Q26740664-6D3B1B20-F8B0-4BD6-AEF0-BA926CAC5BA9 Q26744172-0C113D4E-32D7-4550-B0E7-F97F7D295CE9 Q26744387-4999DC16-A66E-4383-9579-4DEF09475448 Q26746622-29E7F063-DE50-4BC3-82BB-AA4E314E1934 Q26747273-5D6D91C1-7A46-46B5-A45A-C4950FEE07A1 Q26752312-1E59D27D-2350-4AFE-B174-158AD5DF5CD9 Q26752579-F8798A92-4D13-47E2-A8F9-F6D1DB092566 Q26764947-2C7A40EB-C8E6-4D89-930F-606BAA087F15 Q26765758-313E3F45-1D79-4B40-8008-42BEDAAAC872 Q26765854-A920B173-738E-4083-8C58-AC5735869EE4 Q26765855-C43898FD-0616-467C-BDC1-EB90E8EC7D7B Q26766293-A4BF189E-5A12-47F0-84A6-90289E39F95F Q26767169-00A99DC5-67C3-4647-A348-2795D9FF5BDE Q26767392-5EF50531-3F7A-419F-AB85-742B8F55EB31 Q26768680-6AADCF22-E9F1-46A7-9AD8-FAC48CE4A1FA Q26771513-1BF96951-D402-4612-958F-CBB44EEDEF84 Q26773514-12E55DEB-DE99-48F4-AB71-60D0D4B25D27 Q26774717-E22AC4B1-9F90-46F5-ACF6-56AC70C44F13 Q26776307-639077F1-B0BB-4E3F-BA2E-C1E9FB82091E Q26781836-F3066037-C8ED-4D1A-AC44-C266694F5013 Q26795601-E3BA198D-F186-4D60-B272-334F3B6A6CC0 Q26797282-3EB3F3DD-95C7-48CB-A3E5-AC904254E185 Q26799854-117D0692-5956-4A0D-91C2-939E6C270D86

P2860

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

http://www.wikidata.org/entity/Q29547224

description

2009 nî lūn-bûn

@nan

2009 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Effects of radiotherapy with c ...... alysis of the EORTC-NCIC trial

@ast

Effects of radiotherapy with c ...... alysis of the EORTC-NCIC trial

@en

type

label

Effects of radiotherapy with c ...... alysis of the EORTC-NCIC trial

@ast

Effects of radiotherapy with c ...... alysis of the EORTC-NCIC trial

@en

prefLabel

Effects of radiotherapy with c ...... alysis of the EORTC-NCIC trial

@ast

Effects of radiotherapy with c ...... alysis of the EORTC-NCIC trial

@en

P1433

Q29547224-E1D514DA-9B26-463D-B66B-0C1BE6E73CBB

P1476

Q29547224-12C81C08-442B-40B0-B24C-6A69568988AE

P2093

Q29547224-070A254B-CF68-4F75-BA8B-2FD9CDCE47C1

Q29547224-190B253F-B32D-4766-87A8-C7A11AF16F64

Q29547224-1C17F676-A068-4C9F-8A96-7662F9BBF17A

Q29547224-1D85C662-D2F5-4FE9-A994-1026AE634740

Q29547224-4BECCD9E-35DD-44C4-9172-994C2145CF2F

Q29547224-582F4D1C-77FE-4613-93BF-62E40D4EF37A

Q29547224-676C44CB-FFB8-4EFA-9AFE-285C3A6B0C2B

Q29547224-6BBA6659-635D-49C9-A5B6-49B47AAC6E40

Q29547224-6F3E1EEE-3C58-4A5D-9C59-DB36A0BBCE9F

Q29547224-72E6B15C-45C5-446D-9B02-910722857F3D

P304

Q29547224-6C42B5CA-4B15-4231-9CB8-A413ECDFC800

P31

Q29547224-67270E52-FDBF-4FE6-BDAD-E5172B759975

P3181

Q29547224-E9F00DFD-E69C-4555-8994-6A57474E3745

P356

Q29547224-6DE6D370-5DF8-4129-8E2C-DAA89E4CE937

P407

Q29547224-C97F294B-107C-4FBF-BFD4-60E4EB0A91CE

P433

Q29547224-15B5E699-4ADC-4019-B5D9-A1D4F45B59E4

P478

Q29547224-6B24697D-9564-4132-84BC-41185A8F72D2

P577

Q29547224-3353FFCF-6442-4A88-ACD5-A3DBE4229718

P698

Q29547224-88359979-3F4A-4026-8C3C-46C43ABBD364

P921

Q29547224-E1281FA7-9C28-4250-A317-AC25CDB4E8F2

Q29547224-EBDD81CD-FC1B-4B30-A27A-D89CA77F9ACC

P3181

P356

S1470-2045(09)70025-7

P1433

The Lancet Oncology

P1476

Effects of radiotherapy with c ...... alysis of the EORTC-NCIC trial

@en

P2093

Allgeier A

http://www.w3.org/2001/XMLSchema#string

Belanger K

http://www.w3.org/2001/XMLSchema#string

Brandes AA

http://www.w3.org/2001/XMLSchema#string

Cairncross JG

http://www.w3.org/2001/XMLSchema#string

Eisenhauer E

http://www.w3.org/2001/XMLSchema#string

Fisher B

http://www.w3.org/2001/XMLSchema#string

Gijtenbeek J

http://www.w3.org/2001/XMLSchema#string

Gorlia T

http://www.w3.org/2001/XMLSchema#string

Hau P

http://www.w3.org/2001/XMLSchema#string

Hegi ME

http://www.w3.org/2001/XMLSchema#string

P304

459-66

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

7656

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/S1470-2045(09)70025-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19269895

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

phase III clinical trial